Financial Ratios

ALPA LABORATORIES LTD.

NSE : ALPABSE : 532878ISIN CODE : INE385I01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE92.032.57 (+2.87 %)
PREV CLOSE ( ) 89.46
OPEN PRICE ( ) 90.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5024
TODAY'S LOW / HIGH ( )90.65 93.45
52 WK LOW / HIGH ( )55.1 115
NSE92.102.4 (+2.68 %)
PREV CLOSE( ) 89.70
OPEN PRICE ( ) 90.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 92.10 (160)
VOLUME 90374
TODAY'S LOW / HIGH( ) 89.50 93.40
52 WK LOW / HIGH ( )55 115
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)6.006.713.451.941.40
   CEPS(Rs)6.637.504.042.481.92
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)68.6962.5655.8552.3950.44
   Tax Rate(%)20.7627.8632.6919.6836.20
Margin Ratios
   Core EBITDA Margin(%)8.699.527.904.021.57
   EBIT Margin(%)17.3817.6611.166.146.66
   Pre Tax Margin(%)17.1417.4411.065.915.93
   PAT Margin (%)13.5812.587.454.743.78
   Cash Profit Margin (%)15.0114.068.716.075.19
Performance Ratios
   ROA(%)7.378.965.183.152.32
   ROE(%)9.1411.346.383.772.82
   ROCE(%)11.3515.549.544.834.78
   Asset Turnover(x)0.540.710.700.660.61
   Sales/Fixed Asset(x)2.743.453.222.932.75
   Working Capital/Sales(x)0.791.041.121.171.10
Efficiency Ratios
   Fixed Capital/Sales(x)0.370.290.310.340.36
   Receivable days166.43119.43112.28115.48129.29
   Inventory Days55.1852.0654.4656.4564.97
   Payable days99.45103.61117.9096.1996.74
Valuation Parameters
   PER(x)8.9610.3510.477.2718.91
   PCE(x)8.119.278.965.6813.78
   Price/Book(x)0.781.110.650.270.53
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.151.340.680.280.72
   EV/Core EBITDA(x)6.127.025.453.768.99
   EV/EBIT(x)6.627.616.064.5810.89
   EV/CE(x)0.600.910.440.190.44
   M Cap / Sales1.221.300.780.350.71
Growth Ratio
   Net Sales Growth(%)-17.2015.0813.4810.2325.25
   Core EBITDA Growth(%)-18.6077.2488.812.10-27.49
   EBIT Growth(%)-18.5082.02106.391.65-31.88
   PAT Growth(%)-10.6394.4578.1338.28-38.11
   EPS Growth(%)-10.6394.4578.1338.28-38.11
Financial Stability Ratios
   Total Debt/Equity(x)0.020.040.000.000.02
   Current Ratio(x)4.954.753.694.544.17
   Quick Ratio(x)4.534.213.183.933.54
   Interest Cover(x)72.3281.61110.9026.469.13
   Total Debt/Mcap(x)0.020.040.000.010.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.